To further elucidate the predictive value of PD-1, PD-L1, and PD-L2 at each timepoint in HMA treatment cycles, receiver operating characteristic (ROC) curves were used to evaluate the potential sensitivity and specificity of factors in predicting AML transformation event. The gene discussed is PDCD1LG2; the disease is acute myeloid leukemia.